Welcome to our dedicated page for Mobix Labs SEC filings (Ticker: MOBXW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Mobix Labs's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Mobix Labs's regulatory disclosures and financial reporting.
Mobix Labs, Inc. implemented a one-for-ten reverse stock split of its Class A and Class B Common Stock, effective at 4:00 p.m. Eastern Time on April 6, 2026. Every 10 shares of common stock were converted into 1 share, with cash paid instead of issuing fractional shares.
The reverse split leaves each stockholder’s percentage ownership essentially unchanged and does not affect the par value or authorized share count. The company is proportionately adjusting shares available under its equity incentive plan and outstanding options and warrants, and each warrant now covers one-tenth of a share at an exercise price of $57.90.
Mobix Labs, Inc. entered into a financing deal with Leviston Resources via a senior secured convertible promissory note with an original principal amount of $3,000,000, sold for $2,550,000. The note bears 10% annual interest from March 31, 2026 and matures on July 31, 2026, when unpaid principal and interest are due in cash unless converted earlier.
Leviston may convert principal and interest into Class A common stock at a price equal to the lesser of the closing price on March 31, 2026 and 85% of the lowest 8-day VWAP before and including the conversion notice date. Following an event of default, obligations increase to 125% of amounts then outstanding. Mobix agreed to file and seek effectiveness of a registration statement to allow resales of conversion shares under the Securities Act.
Mobix Labs, Inc. reported the results of its Annual Meeting of Stockholders held on March 23, 2026. Holders of 43,982,421 shares of Class A Common Stock and 2,004,901 shares of Class B Common Stock were represented, accounting for approximately 52.86% of the total voting power as of the February 27, 2026 record date, which constituted a quorum.
Stockholders elected Class A director nominees David Aldrich and Frederick Goerner, and Class B director nominee Keyvan Samini, with substantial majorities. They also ratified the selection of the independent registered public accounting firm, approved a Reverse Stock Split Proposal, and approved a Warrant Proposal, each with strong levels of support and no broker non-votes recorded.
Mobix Labs, Inc. is asking stockholders to approve four key items at its 2026 virtual annual meeting. Investors will vote on electing Class II directors, ratifying PricewaterhouseCoopers LLP as auditor for the year ending September 30, 2026, and a reverse stock split.
The reverse split would reclassify and combine outstanding Class A and Class B shares at a ratio between 1:10 and 1:50, at the Board’s discretion, primarily to help regain compliance with Nasdaq’s $1.00 minimum bid price after a prior deficiency notice and extension through April 27, 2026.
Stockholders are also asked to approve, under Nasdaq Listing Rule 5635(d), potential issuance of up to 8,229,701 Class A shares on exercise of an Inducement Warrant, 384,053 shares on Placement Agent Warrants, and 1,000,000 shares on an additional warrant related to amended outstanding warrants.
Mobix Labs, Inc. is registering the resale of up to 24,127,116 shares of its Class A Common Stock for existing selling stockholders. The company itself is not selling shares and will receive no proceeds from these resales.
The registered shares include stock issued in financings and acquisitions, such as 16,161,787 warrant shares and 3,856,854 shares issued for the RaGE Systems acquisition. As of January 31, 2026, Mobix had 101,072,226 Class A and 2,004,901 Class B shares outstanding.
Mobix may receive up to approximately $15.6 million in gross cash proceeds only if certain outstanding warrants covered by this registration are exercised for cash. The filing emphasizes that the registered block is large, representing about 23.9% of Class A shares, and that resales, or expectations of resales, could significantly pressure the stock price.
MOBIX LABS ownership disclosure: Armistice Capital, LLC and Steven Boyd report beneficial ownership of 3,377,508 shares of Common Stock, representing 4.99% of the class as of 12/31/2025. The filing states Armistice Capital exercises voting and investment power over the shares held by Armistice Capital Master Fund Ltd.
The reporting persons file jointly under Rule 13d-1(k) and note the Master Fund has the right to receive dividends or sale proceeds. Signatures are dated 02/17/2026.
Mobix Labs, Inc. reported a net loss of $10.1 million for the three months ended December 31, 2025, narrower than the $19.8 million loss a year earlier. Revenue fell to $1.9 million from $3.2 million, with both product and services sales declining.
Gross profit dropped to $0.6 million, and interest expense increased to $1.4 million as total debt reached $6.3 million. Despite lower operating expenses, especially stock-based compensation, the company ended the quarter with only $0.3 million in cash, prompting a going concern warning about its ability to meet obligations over the next year.
Stockholders’ equity improved to $4.7 million from a deficit at September 30, 2025, helped by share issuances and warrant reclassification. After quarter-end, Mobix raised approximately $5.1 million net through a public offering of 30 million Class A shares at $0.20 each and issued additional make-whole shares to a lender.
Mobix Labs CEO Philip Sansone filed a Form 4 showing an automatic tax-related sale of shares. On February 2, 2026, Sansone sold 87,025 shares of Mobix Labs Class A common stock at a weighted-average price of $0.188 per share in a transaction coded as a sale.
According to the disclosure, the shares were sold solely to cover taxes arising from restricted stock units that vested on January 31, 2026, under a pre‑set “sell to cover” election, meaning the trades were not discretionary. After this transaction, Sansone directly beneficially owned 1,848,816 shares of Mobix Labs.
Mobix Labs, Inc. insider activity is disclosed in a Form 144 notice covering planned sales of common stock. The filing shows an intention to sell 87,025 shares of common stock through J.P. Morgan Securities LLC on NASDAQ, with an aggregate market value of 16,360.04 and 58,624,989 shares outstanding.
The seller, Philip Sansone, previously acquired 200,000 common shares on 01/31/2026 via RSU vesting from Mobix Labs, Inc. as equity compensation, with payment dated 02/03/2026. Over the prior three months, he sold 100,044 common shares for gross proceeds of 41,219.83 on 11/21/2025.
Mobix Labs, Inc. received an amended Schedule 13G/A showing that Vernon Davis Grizzard III and Sage Hill Investors, LLC together beneficially own 3,142,857 shares of its Class A common stock, representing 4.9% of the class as of December 31, 2025.
The reporting persons have sole voting power over 3,142,857 shares and sole dispositive power over 1,642,857 shares, with no shared voting or dispositive power. They certify that the securities were not acquired and are not held for the purpose of changing or influencing control of Mobix Labs.